Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. China Pharma Holding's shares outstanding for the quarter that ended in Mar. 2026 was 40.52 Mil.
China Pharma Holding's quarterly shares outstanding
increased
from Dec. 2025 (15.52 Mil) to Mar. 2026 (40.52 Mil).
It means China Pharma Holdingissued new shares from Dec. 2025 to Mar. 2026 .
China Pharma Holding's annual shares outstanding
increased
from Dec. 2024 (3.26 Mil) to Dec. 2025 (15.52 Mil).
It means China Pharma Holdingissued new shares from Dec. 2024 to Dec. 2025 .
China Pharma Holding (STU:XQJ) Shares Outstanding (EOP) Explanation
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
China Pharma Holding Shares Outstanding (EOP) Related Terms
China Pharma Holding Shares Outstanding (EOP) Historical Data
* Premium members only.
The historical data trend for China Pharma Holding's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding Shares Outstanding (EOP) Chart
STU:XQJ vs TXMD, RMTI, AYTU: Shares Outstanding (EOP) Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Pharma Holding Shares Outstanding (EOP) vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's Shares Outstanding (EOP) falls into.
China Pharma Holding Shares Outstanding (EOP) Calculation
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
What does a Shares Outstanding (EOP) of 40.52 Mil mean?
China Pharma Holding (STU:XQJ) has a Shares Outstanding (EOP) of 40.52 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on China Pharma Holding and its competitors.
Is China Pharma Holding's Shares Outstanding (EOP) too high?
China Pharma Holding's current Shares Outstanding (EOP) is 40.52 Mil. Overall, China Pharma Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China Pharma Holding's Shares Outstanding (EOP) compare to TXMD and RMTI?
China Pharma Holding's Shares Outstanding (EOP) of 40.52 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on China Pharma Holding and its competitors. China Pharma Holding's current Shares Outstanding (EOP) is 40.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Pharma Holding stock overvalued right now?
China Pharma Holding (STU:XQJ) has a current Shares Outstanding (EOP) of 40.52 Mil. The stock's GF Value™ is €10.05, compared to a current price of €26.80 — trading 166.7% above its estimated fair value. The current Shares Outstanding (EOP) is 40.52 Mil. China Pharma Holding's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For China Pharma Holding (STU:XQJ), the current Shares Outstanding (EOP) is 40.52 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Pharma Holding (STU:XQJ) Overvalued in 2026?
Based on GuruFocus' analysis, China Pharma Holding stock appears to be overvalued.
The current stock price of €26.80 is trading 166.7% above its estimated GF Value™ of €10.05.
Key valuation signals for STU:XQJ:
Shares Outstanding (EOP): 40.52 Mil
GF Value™: €10.05 vs. price of €26.80 (166.7% above fair value)
No single metric tells the full story. See the STU:XQJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
26GF Score
Get the complete analysis for STU:XQJ
Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:XQJ has been successfully added to your 
